To advocate the value of genomics, biotech and medical technologies as these new modalities enter and impact the healthcare system and thereby improving patient outcomes, improving quality and bringing value to the market place.  Members of the Institute include medical directors from purchasers, plans and provider systems.

  • Mission
    Be the recognized leader in bringing information to the forefront that positively impacts patient outcomes through the use of new technologies
  •  Vision
    Enhancing the competency of all affected stakeholders and broadening awareness of new technologies that will impact patient outcomes